- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Changing Practice Patterns in CKD
Closing out the discussion, an expert in chronic kidney disease (CKD) highlights how care for patients with CKD may change in the future based on data presented at AMCP.
EP: 1.CKD: Healthcare Resource Utilization
EP: 2.New Data From AMCP: DAPA-CKD Study
EP: 3.Findings From the DAPA-CKD Study: Reductions in Healthcare Resource Utilization
EP: 4.Analysis from DAPA-CKD: Time-to-Event and Cost Consequence
EP: 5.Results from DAPA-CKD: Time-to-Event and Cost Consequence
EP: 6.Implications of Dapagliflozin Analysis in CKD
EP: 7.IgA Nephropathy Data: US Incident Population
EP: 8.Clinical and Humanistic Burden of IgA Nephropathy
EP: 9.Changing Practice Patterns in CKD
Robert Toto, MD: I think that payers can play an important role in advancing the care of patients with chronic kidney disease by recognizing the value of new drugs that come into practice and focusing on the value of using these drugs in the overall care of the patient. That is to say, payers paying for drugs that are relatively expensive but where the benefit really outweighs the cost. I’m sure this is on their minds, and I’m sure they talk about it all the time. I think that a closer working relationship between payers, health systems, the FDA, and the drug manufacturers could help to facilitate the improvement of the outcomes of patients with chronic kidney disease. That’s why I would urge them to take that, if you will, “team approach” to helping patients, getting these medications into the hands of providers, and educating them on how to use the medication safety. Here we’re speaking specifically about dapagliflozin. I want to take it from the perspective of advancing care of chronic kidney disease with use of gliflozins like dapagliflozin.
This is where the payers can take a leading role in driving things that are going to help our patients and at the same time reduce overall costs to the health care systems. That includes the insurers who would not only pay for the drug but would also pay for the hospitalization. It’s very oversimplistic, but if it’s a lot cheaper to [pay for] a medication that’s going to keep a patient out of the hospital or off of dialysis, then it’s going to cost the payer less over time.
Transcript edited for clarity.
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
Dr Madeleine McDowell Discusses How CKD Disparities, Social Challenges Impact Health Care Access
October 4th 2023Madeleine McDowell, MD, hopes these data insights will help change providers' behavior in terms of adopting earlier and more regular screening for chronic kidney disease (CKD).
Read More
Advocating for All Patients With Chronic Kidney Disease
April 26th 2022Chronic kidney disease is the fastest-growing noncontagious disease in the United States. On this episode of Managed Care Cast, we speak with Mike Spigler, vice president of patient support and education for the American Kidney Fund, who is spearheading the Unknown Causes of Kidney Disease Project, which aims to help underserved patients get to the root cause of their kidney disease, while also helping to solve this mystery for a broader patient population.
Listen
![[Nurse recording dialysis] Credit: iStock](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fajmc%2Fd0325805e4fd25df9227eeacb118e8ccbaf0dd99-612x408.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "[Nurse recording dialysis] Credit: iStock")
